- Home
- AMRC vs NNNN Comparison
AMRC vs NNNN Comparison
Compare AMRC & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRC
- NNNN
- Stock Information
- Founded
- AMRC 2000
- NNNN 2021
- Country
- AMRC United States
- NNNN Germany
- Employees
- AMRC N/A
- NNNN N/A
- Industry
- AMRC Engineering & Construction
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AMRC Consumer Discretionary
- NNNN Health Care
- Exchange
- AMRC Nasdaq
- NNNN Nasdaq
- Market Cap
- AMRC 2.2B
- NNNN 2.2B
- IPO Year
- AMRC 2010
- NNNN 2025
- Fundamental
- Price
- AMRC $40.95
- NNNN $23.34
- Analyst Decision
- AMRC Buy
- NNNN
- Analyst Count
- AMRC 8
- NNNN 0
- Target Price
- AMRC $25.50
- NNNN N/A
- AVG Volume (30 Days)
- AMRC 698.9K
- NNNN 76.8K
- Earning Date
- AMRC 11-03-2025
- NNNN 11-11-2025
- Dividend Yield
- AMRC N/A
- NNNN N/A
- EPS Growth
- AMRC 9.21
- NNNN N/A
- EPS
- AMRC 1.17
- NNNN 0.06
- Revenue
- AMRC $1,858,653,000.00
- NNNN $8,185,146.00
- Revenue This Year
- AMRC $10.00
- NNNN N/A
- Revenue Next Year
- AMRC $9.09
- NNNN N/A
- P/E Ratio
- AMRC $34.85
- NNNN $426.55
- Revenue Growth
- AMRC 22.85
- NNNN 21.95
- 52 Week Low
- AMRC $8.49
- NNNN $5.18
- 52 Week High
- AMRC $44.93
- NNNN $55.65
- Technical
- Relative Strength Index (RSI)
- AMRC 60.27
- NNNN 34.85
- Support Level
- AMRC $40.52
- NNNN $21.60
- Resistance Level
- AMRC $42.83
- NNNN $30.65
- Average True Range (ATR)
- AMRC 2.33
- NNNN 2.47
- MACD
- AMRC -0.42
- NNNN -0.15
- Stochastic Oscillator
- AMRC 48.51
- NNNN 18.71
About AMRC Ameresco Inc.
Ameresco Inc provides energy efficiency solutions for facilities in North America and Europe. It focuses on projects that reduce energy, also focuses on the operations and maintenance costs of governmental, educational, utility, healthcare, and other institutional, commercial, and industrial entities facilities. Ameresco distributes solar energy products and systems, such as PV panels, solar regulators, solar charge controllers, inverters, solar-powered lighting systems, solar-powered water pumps, solar panel mounting hardware, and other system components. The company's segment includes U.S. Regions; U.S. Federal; Canada; Alternative Fuels; Non-Solar DG and All Other. It derives a majority of its revenue from the U.S. Regions segment.
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.